Jan Stoehlmacher-Williams

Author

University Hospital Carl Gustav Carus

Also Known As

J. Stoehlmacher-Williams, Jan Stoehlmacher-Williams

Publications

618

Citations

H-Index

Concepts

All Affiliations

University Hospital Carl Gustav Carus Heidelberg University Goethe University Frankfurt Universitätsklinikum Aachen RWTH Aachen University

About

Jan Stoehlmacher-Williams is an author at University Hospital Carl Gustav Carus specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	336
2	Immunology	3	3	78
3	Gastroenterology	2	2	299
4	Health Sciences	1	1	24
5	Hepatology	1	1	258

Jan Stoehlmacher-Williams

Publications

421

Citations

H-Index

Page 1

	Year	Citations
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study) Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein, Annals of Oncology Surgical OncologyHepatologyGastrointestinal OncologyMedicineGastroenterology	2014	258
Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Linnea Stenholm, Jan Stoehlmacher-Williams, Salah‐Eddin Al‐Batran, Annals of Oncology Advanced Gastric CancerMedicineImmunologyGastroenterologyPathology	2013	41
Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer Gunnar Folprecht, Susanne Hamann, Katharina Schütte, BMC Cancer	2014	36
EGFR, FLT1 and Heparanase as Markers Identifying Patients at Risk of Short Survival in Cholangiocarcinoma Andreas-Claudius Hoffmann, Eray Goekkurt, Peter V. Danenberg, PLoS ONE	2013	25
Safety and efficacy of panitumumab (pmab) in HPV-positive (+) and HPV-negative (-) recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Analysis of the global phase III SPECTRUM trial. Jan Stoehlmacher-Williams, Cristian Villanueva, Paolo Foa, Journal of Clinical Oncology Squamous Cell CarcinomaImmunologyPathologyImmunotherapeuticsImmunotherapy	2012	24
Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC). Jan Stoehlmacher-Williams, L. Obermann, Gerhard Ehninger, PubMed	2012	24
Messenger RNA vaccination and B-cell responses in NSCLC patients. Martin Sebastian, Lotta von Boehmer, Alfred Zippelius, Journal of Clinical Oncology Maturation MarkersHumoral ResponseImmunologyImmunotherapeuticsImmune System	2012	13

Page 1